𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate

✍ Scribed by Daniel J George

Book ID
117264366
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
238 KB
Volume
60
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Platelet-derived growth factor receptor
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
✍ Tadahiko Kubo; Sajida Piperdi; Jeremy Rosenblum; Cristina R. Antonescu; Wen Chen πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 474 KB πŸ‘ 2 views

## Abstract The purpose of this review was to determine whether imatinib mesylate (STI571, Gleevec) has a role in the treatment of osteosarcoma. The expression of platelet‐derived growth factor (PDGF) receptor and its ligand was examined in a panel of surgical specimens obtained from 54 osteosarcom